These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 34713240)
1. Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells. Allen D; Rosenberg M; Hendel A Front Genome Ed; 2020; 2():617910. PubMed ID: 34713240 [TBL] [Abstract][Full Text] [Related]
2. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity. Basila M; Kelley ML; Smith AVB PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845 [TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
4. Chemical Modification of CRISPR Schubert MS; Cedrone E; Neun B; Behlke MA; Dobrovolskaia MA J Cytokine Biol; 2018; 3(1):. PubMed ID: 30225466 [TBL] [Abstract][Full Text] [Related]
5. RNA-guided genome editing in plants using a CRISPR-Cas system. Xie K; Yang Y Mol Plant; 2013 Nov; 6(6):1975-83. PubMed ID: 23956122 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Genome Editing Using CRISPR/Cas9. Ding Y; Li H; Chen LL; Xie K Front Plant Sci; 2016; 7():703. PubMed ID: 27252719 [TBL] [Abstract][Full Text] [Related]
7. Cas9/gRNA-mediated genome editing of yeast mitochondria and Yoo BC; Yadav NS; Orozco EM; Sakai H PeerJ; 2020; 8():e8362. PubMed ID: 31934513 [TBL] [Abstract][Full Text] [Related]
8. Clearance of residual genome editing components used for ex vivo genome-editing of allogeneic cell therapy products. Chialastri A; Hoffman H; Fink D; Dashnau JL Cytotherapy; 2024 Jul; ():. PubMed ID: 39023463 [TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase. You H; Mayer JU; Johnston RL; Sivakumaran H; Ranasinghe S; Rivera V; Kondrashova O; Koufariotis LT; Du X; Driguez P; French JD; Waddell N; Duke MG; Ittiprasert W; Mann VH; Brindley PJ; Jones MK; McManus DP FASEB J; 2021 Jan; 35(1):e21205. PubMed ID: 33337558 [TBL] [Abstract][Full Text] [Related]
15. CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization. Chung SH; Sin TN; Dang B; Ngo T; Lo T; Lent-Schochet D; Meleppat RK; Zawadzki RJ; Yiu G Mol Ther Nucleic Acids; 2022 Jun; 28():613-622. PubMed ID: 35614998 [TBL] [Abstract][Full Text] [Related]
16. Engineering nucleic acid chemistry for precise and controllable CRISPR/Cas9 genome editing. Cai W; Wang M Sci Bull (Beijing); 2019 Dec; 64(24):1841-1849. PubMed ID: 36659580 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Gene Editing in Yeast: A Molecular Biology and Bioinformatics Laboratory Module for Undergraduate and High School Students. Sankaran SM; Smith JD; Roy KR J Microbiol Biol Educ; 2021; 22(2):. PubMed ID: 34594460 [TBL] [Abstract][Full Text] [Related]
18. Selection of extended CRISPR RNAs with enhanced targeting and specificity. Herring-Nicholas A; Dimig H; Roesing MR; Josephs EA Commun Biol; 2024 Jan; 7(1):86. PubMed ID: 38212640 [TBL] [Abstract][Full Text] [Related]
19. Efficiency of potato genome editing: Targeted mutation on the genes involved in starch biosynthesis using the CRISPR/dMac3-Cas9 system. Kusano H; Takeuchi A; Shimada H Plant Biotechnol (Tokyo); 2023 Sep; 40(3):201-209. PubMed ID: 38420566 [TBL] [Abstract][Full Text] [Related]
20. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species. Wang P mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980 [No Abstract] [Full Text] [Related] [Next] [New Search]